ÂÜÀòÂÒÂ×

Ken Myszkowski is currently the Chief Financial Officer at Arrowhead Pharmaceuticals, Inc., a biotechnology company specializing in targeted therapeutics and siRNA delivery. Prior to their current role, Ken has held various financial positions in companies such as Broadwind Energy, Primary Energy Recycling Corp, NanoInk, Inc, and Delphion, Inc. Ken has a BA in Accounting from the University of Illinois Urbana-Champaign and an MBA in Finance from The University of Chicago Booth School of Business. Ken has a diverse background in finance, having also worked in public accounting at Arthur Andersen & Co. and in roles such as Corporate Controller and Senior Analyst in industries ranging from wind energy to nanotechnology.